Showing results (111-120 of 166) with videos related to
Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|June 10, 1998
Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in womenT Ohtsu, H Fujii, H Wakita, et al.Japanese Journal of Clinical Oncology|December 1, 1995
The confusion associated with breast cancer chemotherapy in Japan: the first year's experience at the Division of Oncology and Hematology, National Cancer Center Hospital EastT Ohtsu, Y Sasaki, H Fujii, et al.The Journal of Toxicological Sciences|August 1, 1985
[Fertility study on halopredone acetate in rats]S Imoto, A Yahata, M Kosaka, et al.The Journal of Toxicological Sciences|August 1, 1985
[Teratogenicity study on halopredone acetate in rats]S Imoto, S Kamada, A Yahata, et al.Bioinformatics (Oxford, England)|July 21, 2004
Predicting gene regulation by sigma factors in Bacillus subtilis from genome-wide dataM J L de Hoon, Y Makita, S Imoto, et al.American Journal of Hematology|December 10, 1999
Soluble fas ligand in natural killer cell lymphomaT Murayama, T Koizumi, H Das, et al.British Journal of Haematology|April 7, 1999
Levels of soluble FasL and FasL gene expression during the development of graft-versus-host disease in DLT-treated patientsH Das, S Imoto, T Murayama, et al.Breast Cancer Research and Treatment|November 18, 2000
A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer SocietyM Noguchi, K Motomura, S Imoto, et al.Japanese Journal of Clinical Oncology|September 28, 2001
Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimensY Shigeoka, K Itoh, T Igarashi, et al.QJM : Monthly Journal of the Association of Physicians|June 10, 2021
Living with COVID-19: mass gatherings and minimizing riskM Murakami, T Yasutaka, M Onishi, et al.Pageof 17